In Vitro and In Vivo Evaluation of GSK-3 Radioligands in Alzheimer's Disease: Preliminary Evidence of Sex Differences.
Journal
ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411
Informations de publication
Date de publication:
13 Aug 2021
13 Aug 2021
Historique:
received:
11
05
2021
entrez:
23
8
2021
pubmed:
24
8
2021
medline:
24
8
2021
Statut:
epublish
Résumé
Glycogen synthase kinase-3 (GSK-3) is a positron emission tomography (PET) imaging target with implications in the pathogenesis of Alzheimer's disease (AD). This preliminary study evaluates human AD and transgenic P301L mouse brain tissues using the GSK-3-targeting radiotracers [
Identifiants
pubmed: 34423266
doi: 10.1021/acsptsci.1c00132
pmc: PMC8369674
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1287-1294Subventions
Organisme : NIA NIH HHS
ID : R01 AG052414
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054473
Pays : United States
Informations de copyright
© 2021 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
EMBO J. 1990 Aug;9(8):2431-8
pubmed: 2164470
Mol Cell Neurosci. 2004 Mar;25(3):363-73
pubmed: 15033165
Ann N Y Acad Sci. 2005 Jun;1052:210-24
pubmed: 16024764
Alzheimers Dement. 2018 Sep;14(9):1171-1183
pubmed: 29907423
Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9601-5
pubmed: 27355874
J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
pubmed: 2384545
Front Neuroendocrinol. 2009 Jul;30(2):239-58
pubmed: 19427328
J Fluor Chem. 2021 May;245:
pubmed: 33840834
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6612-7
pubmed: 9192613
Mol Imaging Biol. 2020 Aug;22(4):832-841
pubmed: 31728839
Nat Genet. 2000 Aug;25(4):402-5
pubmed: 10932182
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1140-5
pubmed: 11805297
Cell Mol Life Sci. 2016 Jan;73(1):201-15
pubmed: 26198711
Nucl Med Biol. 2008 Nov;35(8):805-15
pubmed: 19026942
J Biol Chem. 2005 Feb 4;280(5):3963-73
pubmed: 15509565
Front Mol Neurosci. 2011 Oct 05;4:24
pubmed: 22007157
J Alzheimers Dis. 2017;56(4):1279-1292
pubmed: 28157099
J Neurochem. 2008 Mar;104(6):1433-9
pubmed: 18088381
Mol Neurodegener. 2017 Dec 22;12(1):89
pubmed: 29273078
J Alzheimers Dis. 2015;50(3):847-57
pubmed: 26836168
Neuroimage. 2008 Aug 1;42(1):60-9
pubmed: 18502665
Mol Chem Neuropathol. 1996 Oct-Dec;29(2-3):253-61
pubmed: 8971700
Neuroscience. 2005;132(3):581-9
pubmed: 15837120
Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66
pubmed: 20535591
Alzheimers Dement. 2016 Nov;12(11):1186-1196
pubmed: 27692800
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
J Med Chem. 2019 Nov 14;62(21):9600-9617
pubmed: 31535859
Neurobiol Aging. 2009 Jan;30(1):1-13
pubmed: 17590238
Brain Imaging Behav. 2017 Feb;11(1):205-213
pubmed: 26843008